Alembic Pharmaceuticals Ltd. Soars to 52-Week High, Receives 'Buy' Call from MarketsMOJO
Alembic Pharmaceuticals Ltd. has been making headlines in the pharmaceutical industry with its recent stock performance. On January 24th, 2024, the company's stock price reached a 52-week high of Rs. 991.1, outperforming the sector by 2.83%. With a 'Buy' call from MarketsMojo and consistently strong performance, Alembic Pharmaceuticals Ltd. is a promising investment opportunity in the pharma market.
Alembic Pharmaceuticals Ltd., a midcap pharmaceutical company, has been making waves in the industry with its recent stock performance. On January 24th, 2024, the company's stock price reached a 52-week high of Rs. 991.1, showcasing its strong growth and potential in the market.
According to MarketsMOJO, a leading financial analysis platform, Alembic Pharmaceuticals Ltd. has been given a 'Buy' call, further solidifying its position as a promising investment opportunity. The stock has also outperformed the sector by 2.83% and reached an intraday high of Rs. 991.1, a significant increase of 5.22%.
In addition to its recent high, Alembic Pharmaceuticals Ltd. has been consistently performing well in the market. The stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong and steady upward trend.
Moreover, the company's 1-year performance has been impressive, with a growth of 78.38% compared to the Sensex's performance of 16.26%. This showcases Alembic Pharmaceuticals Ltd.'s ability to outperform the market and deliver positive returns to its investors.
With its strong performance and positive outlook, Alembic Pharmaceuticals Ltd. is definitely a company to watch out for in the pharma industry. Its consistent growth and promising future make it a potential investment opportunity for those looking to diversify their portfolio.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
